BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12646970)

  • 1. Effect of the surface potential of the hemodialysis membrane and the electrical charge of the gadolinium contrast medium on dialyzability.
    Okada S; Inoue K; Kijima T; Katagiri K; Kumazaki T
    J Nippon Med Sch; 2003 Feb; 70(1):12-5. PubMed ID: 12646970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clearance of gadolinium contrast agent by hemodialysis: in vitro and clinical studies].
    Katagiri K; Okada S; Kumazaki T; Tsuboi N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Nov; 58(13):739-44. PubMed ID: 9866990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability of gadolinium-DTPA through two types of hemodialysis membrane.
    Ueda J; Furukawa T; Yamamoto T; Sakaguchi K; Araki Y
    Invest Radiol; 1998 Oct; 33(10):734-7. PubMed ID: 9788135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of gadolinium chelates by hemodialysis: an in vitro study.
    Choyke PL; Girton ME; Vaughan EM; Frank JA; Austin HA
    J Magn Reson Imaging; 1995; 5(4):470-2. PubMed ID: 7549213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of Gd³⁺ to the glycosaminoglycan heparin.
    Taupitz M; Stolzenburg N; Ebert M; Schnorr J; Hauptmann R; Kratz H; Hamm B; Wagner S
    Contrast Media Mol Imaging; 2013; 8(2):108-16. PubMed ID: 23281283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability of iodinated and MR contrast media through two types of hemodialysis membrane.
    Ueda J; Furukawa T; Higashino K; Yamamoto T; Ujita H; Sakaguchi K; Araki Y
    Eur J Radiol; 1999 Jul; 31(1):76-80. PubMed ID: 10477103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes.
    Randoux C; Gillery P; Georges N; Lavaud S; Chanard J
    Kidney Int; 2001 Oct; 60(4):1571-7. PubMed ID: 11576375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption of nafamostat mesilate by hemodialysis membranes.
    Inagaki O; Nishian Y; Iwaki R; Nakagawa K; Takamitsu Y; Fujita Y
    Artif Organs; 1992 Dec; 16(6):553-8. PubMed ID: 1482323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a polyacrylonitrile membrane and a membrane made of regenerated cellulose on the plasma concentrations of erythropoietin during hemodialysis.
    Opatrný K; Krouzecký A; Wirth J; Vít L; Eiselt J
    Artif Organs; 1998 Oct; 22(10):816-20. PubMed ID: 9790077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do high-flux dialysis membranes affect renal dyslipidemia?
    Ottosson P; Attman PO; Knight C; Samuelsson O; Weiss L; Alaupovic P
    ASAIO J; 2001; 47(3):229-34. PubMed ID: 11374763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodixanol is readily eliminated by hemodialysis.
    Berg KJ; Rolfsen B; Stake G
    Acta Radiol; 1998 Jul; 39(4):372-4. PubMed ID: 9685821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
    Stuard S; Bonomini M; Settefrati N; Albertazzi A
    Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AN69: Evolution of the world's first high permeability membrane.
    Thomas M; Moriyama K; Ledebo I
    Contrib Nephrol; 2011; 173():119-129. PubMed ID: 21865784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis clearance of iosimenol, a novel iso-osmolar radiographic contrast medium.
    Hirao Y; Kashiyama E; Umehara K; Kohno M; Ikei N; Hogstrom B
    Acta Radiol; 2014 Oct; 55(8):938-44. PubMed ID: 24123996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialyzability of gadodiamide in hemodialysis patients.
    Saitoh T; Hayasaka K; Tanaka Y; Kuno T; Nagura Y
    Radiat Med; 2006 Jul; 24(6):445-51. PubMed ID: 16958426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T.
    Shen Y; Goerner FL; Snyder C; Morelli JN; Hao D; Hu D; Li X; Runge VM
    Invest Radiol; 2015 May; 50(5):330-8. PubMed ID: 25658049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties.
    Fabbrini P; Sirtori S; Casiraghi E; Pieruzzi F; Genovesi S; Corti D; Brivio R; Gregorini G; Como G; Carati ML; Viganò MR; Stella A
    Blood Purif; 2013; 35 Suppl 2():52-8. PubMed ID: 23676837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis.
    Matzke GR; Frye RF; Joy MS; Palevsky PM
    Pharmacotherapy; 2000 Jun; 20(6):635-43. PubMed ID: 10853618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA.
    Runge VM
    J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.